Educational guide
Gonadorelin (GnRH) Dosing, Need to Know Information, Safety, Stacks, Dosing Calculator and more!
How much do I take? Is this right for me? How do I use it? Is it safe? How do I know it's working? Compound Profile Scientific & Efficacy Data C55H75N17O13 Molecular Formula 1182.3 Molecular Weight 2-4 minutes Half-Life Varies by route: ~5-20% (intranasal), 10
This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.
How much do I take?
Is this right for me?
How do I use it?
Is it safe?
How do I know it's working?
Compound Profile
Scientific & Efficacy Data
C55H75N17O13
Molecular Formula
1182.3
Molecular Weight
2-4 minutes
Half-Life
Varies by route: ~5-20% (intranasal), 100% (IV/IM injections)
Bioavailability
34973-08-5
CAS #
638793
PubChem ID ↗
Developed By · 1971
Research Team
Academic Research Institutions
Primary Benefits
Gonadorelin directly controls your body's fertility hormones, making it one of the most fundamental tools for supporting natural reproduction and addressing fertility challenges.
By triggering the release of LH and FSH, gonadorelin helps restore natural hormonal rhythms and balance in your reproductive system.
Gonadorelin works to promote healthy ovulation timing and quality, which is essential for conception and reproductive success.
Amino Acid Sequence
Dosing
How muchdo I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Standard Dose
100 mcg
Frequency
Single dose
Duration
One-time diagnostic test
FDA-labeled gonadotropin (LH/FSH) stimulation test for pituitary reserve; 100 mcg given once subcutaneously (or IV), with LH measured at 0, 15, 30, 45, 60 and 120 minutes (Factrel) [4].
Timing
Best time to take
Administer Gonadorelin (GnRH) at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Gonadorelin (GnRH) injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Gonadorelin (GnRH) should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting Your Dose
Increase if
+You've tolerated the current dose for the recommended period without significant side effects
+Therapeutic goals haven't been met at the current dose level
+Your healthcare provider recommends dose escalation based on your response
+Lab work or clinical assessments support a higher dose
Decrease if
-Side effects are bothersome or impacting daily life despite management strategies
-You experience any signs of an adverse reaction
-Lab results indicate the need for dose reduction
-Your healthcare provider recommends a lower dose based on your response
Signs of right dose
✓Therapeutic goals being met with minimal side effects
✓Stable and consistent response to treatment
✓Lab values or clinical markers trending in the right direction
✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
Suitability
Is thisright for me?
Best For
Improving fertility and conception chances
Gonadorelin (GnRH) is particularly well-suited for individuals focused on improving fertility and conception chances. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Regulating irregular menstrual cycles
Gonadorelin (GnRH) is particularly well-suited for individuals focused on regulating irregular menstrual cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Enhancing reproductive hormone levels
Gonadorelin (GnRH) is particularly well-suited for individuals focused on enhancing reproductive hormone levels. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Supporting natural pregnancy attempts
Gonadorelin (GnRH) is particularly well-suited for individuals focused on supporting natural pregnancy attempts. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider Alternatives If
Goal: Alternative approaches for hormone support support
Consider: Consult your healthcare provider for alternatives to Gonadorelin (GnRH) based on your specific needs and medical history
Goal: Alternative hormone-supporting peptides
Consider: Kisspeptin-10, Gonadorelin, PT-141 (Bremelanotide)
Goal: Non-peptide hormone support
Consider: Clomiphene citrate, Anastrozole, Lifestyle modifications (sleep, exercise)
Who Should Avoid
Do not use if
×Pregnancy or breastfeeding
×Hormone-sensitive cancers (breast, prostate, ovarian)
×Severe pituitary or hypothalamic disease
×Undiagnosed abnormal vaginal bleeding
×Known hypersensitivity to GnRH
Use with caution if
!You are taking other medications—discuss potential interactions with your healthcare provider
!You have a history of liver or kidney disease
!You are elderly or have multiple medical conditions
!You are planning surgery in the near future—inform your surgeon about Gonadorelin (GnRH) use
!You have any chronic health conditions that require regular monitoring
Not Sure?
Compare Gonadorelin (GnRH) with similar peptides to find the best fit for your goals.
Administration
How do Iuse it?
Reconstitution
What you need
•Gonadorelin (GnRH) vial (lyophilized powder or solution)
•Bacteriostatic water or sterile sodium chloride for reconstitution
•Alcohol swabs for cleaning vial tops and injection sites
•Appropriately sized syringes with fine-gauge needles (27-30 gauge)
•Sharps disposal container
Example
Add the recommended volume of bacteriostatic water to the Gonadorelin (GnRH) vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Gonadorelin (GnRH) is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
•Abdomen (stomach area)—at least 2 inches from the belly button, most popular choice for self-injection
•Front of thighs—middle to upper portion of the outer leg
•Back of upper arm—outer area (may need assistance from another person)
Technique
1.Wash your hands thoroughly with soap and water before handling supplies
2.Clean the injection site with an alcohol swab and let it air dry completely
3.Pinch a fold of skin at the chosen injection site
4.Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
5.Inject the medication slowly and steadily over 5-10 seconds
6.Release the skin fold and remove the needle, applying gentle pressure with a clean swab
7.Rotate injection sites to prevent tissue irritation or lipodystrophy
8.Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage
Before reconstitution
Store Gonadorelin (GnRH) in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Gonadorelin (GnRH) should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Solution appears cloudy, discolored, or contains visible particles (should be clear)
Product has been exposed to temperatures outside the recommended storage range
Product has been frozen (unless specifically designed for freeze-thaw stability)
Expiration date has passed or reconstituted solution has exceeded its use-by date
Unusual odor, color change, or visible contamination
Sample Daily Schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Subcutaneous injection—rotate sites if applicable
Maintain a consistent schedule for optimal results with Gonadorelin (GnRH). Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is itsafe?
Safety Profile
Gonadorelin is native GnRH and carries the safety profile established over 40+ years of clinical use in reproductive endocrinology. As the body's natural hormone, it produces minimal local side effects when dosed appropriately. The critical safety concern with gonadorelin is the initial flare effect within 24-48 hours of first dose—temporary elevation in FSH and LH—which can paradoxically suppress sex hormones before the desired stimulation occurs. This flare makes gonadorelin unsuitable for some conditions and explains why synthetic analogs (agonists, antagonists) are preferred in many modern fertility protocols.
Gonadorelin safety is supported by decades of clinical endocrinology practice and FDA approval for pituitary dysfunction (1981) with extensive post-marketing surveillance. Studies published in Fertility and Sterility and Human Reproduction show appropriate dosing produces predictable hormone responses without hepatotoxicity, nephrotoxicity, or significant cardiovascular effects. The flare phenomenon is well-characterized physiologically—not an adverse event but an expected pharmacodynamic response requiring timing consideration.
Common Side Effects
Experienced by some users
Mild headache
Management: Consult your healthcare provider for guidance.
Local injection site reactions (redness, swelling)
Temporary hot flashes
Mood changes or emotional sensitivity
Nausea or mild stomach upset
Allergic skin reactions
Dizziness or lightheadedness
Temporary changes in vision
Joint or muscle aches
Insomnia or sleep disturbances
Severe allergic reactions (difficulty breathing, swelling)
Severe hormonal imbalance symptoms
Ovarian hyperstimulation syndrome (OHSS)
Signs of blood clots (chest pain, leg swelling)
Severe mood changes or depression
Stop and Seek Help If
×Severe or worsening side effects that don't improve with dose adjustment or supportive care
×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
×Your healthcare provider recommends discontinuation based on your clinical response
×Development of any new medical condition that may be contraindicated with Gonadorelin (GnRH)
×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
×Abnormal lab results or clinical markers that suggest adverse effects
Gonadorelin (GnRH) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Interactions
With other peptides
✓Complements GnRH action to stimulate final egg maturation and trigger ovulation
✓Works synergistically with GnRH to promote follicle development and egg production
✓GnRH directly stimulates LH release, making them natural partners in reproductive function
With medications
!GnRH Antagonists - These directly block GnRH action, making them counterproductive when used together
!Dopamine Agonists - Can suppress GnRH release and interfere with its reproductive effects
!Long-acting GnRH Agonists - Initial flare can interfere with gonadorelin's pulsatile signaling mechanism
With supplements
✓Multivitamins - Generally safe to take alongside Gonadorelin (GnRH). Space doses apart if taking oral formulations to ensure optimal absorption.
✓Electrolyte supplements - Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
Does itwork?
Evidence Level
Moderate human trials
What to Expect
Minutes (15-30)
What you might notice
•Your pituitary gland receives the signal and begins preparing to release LH and FSH
•Initial hormone cascades begin
What's normal
•Initial response to Gonadorelin (GnRH) is beginning at the cellular level
•Different individuals experience Gonadorelin (GnRH)'s onset at different rates
•Transient systemic effects from initial Gonadorelin (GnRH) exposure are common
What's next
→Maintain consistent Gonadorelin (GnRH) administration as prescribed
→Document subjective effects and physical markers daily
→Schedule a check-in with your provider about initial observations
Hours (1-4)
•Peak LH and FSH levels are detected in your bloodstream
•Your reproductive system is most active during this window
•Gonadorelin (GnRH) is achieving sufficient receptor engagement
•Initial mechanism of Gonadorelin (GnRH) is taking effect
•Early transient effects from Gonadorelin (GnRH) administration are resolving
Days (3-7)
•In women, follicles in the ovaries grow in response to the hormones
•In men, sperm production increases
•Effects compound with repeated doses
Weeks (1-3)
•Visible changes in ovulation patterns or menstrual cycle regulation
•Sperm parameters may improve in men
•Reproductive hormones stabilize
•Full therapeutic effects of Gonadorelin (GnRH) are well-characterized at this point
•Maintenance of Gonadorelin (GnRH)'s therapeutic effects is typical
•Tolerance patterns with Gonadorelin (GnRH) are generally stable over months
→Comprehensive assessment of Gonadorelin (GnRH) efficacy should be conducted
→Discuss long-term continuation, cycling, or protocol modifications
→Continue regular monitoring of relevant biomarkers or symptoms
Signs It's Working
Treatment Response
✓Improvement in the primary symptoms or condition being treated
✓Positive changes in relevant lab values or clinical markers
✓Consistent, stable response to Gonadorelin (GnRH) over time
✓Reduction in symptom frequency or severity
General Well-being
✓Improved energy levels and daily functioning
✓Better quality of life related to the treated condition
✓Manageable or absent side effects indicating good tolerance
✓Positive feedback from healthcare provider during check-ups
Not Seeing Results?
Common reasons
•Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
•Insufficient time at target dose—most compounds need several weeks to show full benefits
•Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
•Individual variation in response—genetics, metabolism, and other factors affect outcomes
•Underlying conditions or medications interfering with absorption or effectiveness
•Improper storage leading to degraded product—always verify proper storage conditions
Key Research
[1]"Effect of Extended Duration of Progesterone-Based Ovulation Synchronization Protocol on Fertility in Japanese Black Cows"
Bandai K, et al., 2026
Finding: GnRH effectively synchronized ovulation in cattle when combined with progesterone protocols. Extended treatment protocols improved fertility outcomes in Japanese Black cows used in breeding programs.
[2]"Current Treatment for Symptomatic Uterine Fibroids: Available Evidence and Therapeutic Dilemmas"
Research investigators, 2026
Finding: GnRH antagonists improved quality of life and symptom severity without significant fibroid volume reduction compared to placebo. When combined with other medications, GnRH therapy effectively managed fibroid-related symptoms in women.
[3]"Effect of GLP1 Agonists on Reproduction"
Couldwell M, et al., 2025
Finding: GLP-1 agonists demonstrated effects on the GnRH system and reproductive outcomes, including improvements in fertility in obese patients. The review highlighted the complex interactions between metabolic and reproductive hormone axes.
[4]"Factrel (gonadorelin HCl) human diagnostic prescribing information - anterior pituitary gonadotrope (LH) reserve test"
Wyeth (Factrel, gonadorelin hydrochloride) - prescribing information, 1982
Finding: Human Factrel (gonadorelin HCl) is indicated for evaluating the functional capacity and response of the gonadotropes of the anterior pituitary. The diagnostic dose is 100 mcg given as a single subcutaneous or intravenous injection, with serum LH measured at baseline and at 15, 30, 45, 60 and 120 minutes to assess pituitary gonadotropin reserve.
[5]"Efficacy and safety of intravenous pulsatile gonadotropin-releasing hormone (Lutrepulse)"
Santoro N, 1990
Finding: Pulsatile gonadorelin acetate 5 mcg every 90 minutes (range 1-20 mcg) by intravenous pump induced ovulation in hypothalamic amenorrhea; intravenous delivery outperformed subcutaneous.
The Science
Stacking & Combinations
Frequently Asked Questions